3 ms·
Most private research dollars go into patent work-around drugs--drugs that have the same basic function as another, but successfully work around its patent (and
by cma 15y ago
Most private research dollars go into patent work-around drugs--drugs that have the same basic function as another, but successfully work around its patent (and get their own patent in the process). E.g. duplicated effort with occasional serendipity leading to something new.
- refurb 15y agoThis is patently false. Most research dollars go into new therapies with completely new mechanisms of action. Companies are often working in similar areas, that's true. The best example of this is the statins. Lipitor was the 5th statin to hit the market. Was it a me-too drug? I guess, but it was also superior to the other 4 that came out first (less incidence of muscle damage, more efficacious). Did Pfizer say "Gee, let's copy that other statin?" Obviously not since getting a new drug to market takes 10 years and they came out only a few years later.
- aaronblohowiak 15y ago>getting a new drug to market takes 10 years is this intrinsic to drug manufacture? would regulatory/tort reform help?
- refurb 15y agoIt's a combination of the scientific challenges in finding a new drug and the safety hurdles that the FDA puts up. Most of that 10 years is taken up by the clinical trials that the FDA requires. I guess you could say it's the price of having access to thoroughly tested drugs that are both safe and efficacious.